Comparison of Three Serological Methods for the Epidemiological Investigation of TBE in Dogs.
ELISA
IIFA
TBEV
dog
micro-NT
seroprevalence
Journal
Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893
Informations de publication
Date de publication:
15 Feb 2021
15 Feb 2021
Historique:
received:
26
01
2021
revised:
10
02
2021
accepted:
10
02
2021
entrez:
6
3
2021
pubmed:
7
3
2021
medline:
7
3
2021
Statut:
epublish
Résumé
Tick-borne encephalitis (TBE) virus is an emerging pathogen that causes severe infections in humans. Infection risk areas are mostly defined based on the incidence of human cases, a method which does not work well in areas with sporadic TBE cases. Thus, sentinel animals may help to better estimate the existing risk. Serological tests should be thoroughly evaluated for this purpose. Here, we tested three test formats to assess the use of dogs as sentinel animals. A total of 208 dog sera from a known endemic area in Southern Germany were tested in an All-Species-ELISA and indirect immunofluorescence assays (IIFA), according to the manufacturer's instructions. Sensitivity and specificity for both were determined in comparison to the micro-neutralization test (NT) results. Of all 208 samples, 22.1% tested positive in the micro-NT. A total of 18.3% of the samples showed characteristic fluorescence in the IIFA and were, thus, judged positive. In comparison to the micro-NT, a sensitivity of 78.3% and a specificity of 98.8% was obtained. In the ELISA, 19.2% of samples tested positive, with a sensitivity of 84.8% and a specificity of 99.4%. The ELISA is a highly specific test for TBE-antibody detection in dogs and should be well suited for acute diagnostics. However, due to deficits in sensitivity, it cannot replace the NT, at least for epidemiological studies. With even lower specificity and sensitivity, the same applies to IIFA.
Identifiants
pubmed: 33671962
pii: microorganisms9020399
doi: 10.3390/microorganisms9020399
pmc: PMC7919048
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Pfizer Pharma GmbH, Berlin, Germany
ID : WI244427
Références
Clin Infect Dis. 1999 Apr;28(4):882-90
pubmed: 10825054
Vector Borne Zoonotic Dis. 2008 Oct;8(5):713-20
pubmed: 18837668
Berl Munch Tierarztl Wochenschr. 2011 Nov-Dec;124(11-12):443-9
pubmed: 22191165
J Med Virol. 2001 Dec;65(4):730-5
pubmed: 11745938
Parasit Vectors. 2011 Apr 13;4:59
pubmed: 21489255
Viruses. 2020 Oct 31;12(11):
pubmed: 33142676
Emerg Infect Dis. 2017 Dec;23(12):2065-2067
pubmed: 29148377
Ticks Tick Borne Dis. 2014 Oct;5(6):805-9
pubmed: 25113988
Emerg Infect Dis. 2019 Feb;25(2):342-345
pubmed: 30666954
Vector Borne Zoonotic Dis. 2011 Jun;11(6):641-7
pubmed: 21548766
Ticks Tick Borne Dis. 2015 Jun;6(4):489-93
pubmed: 25869034
Vet Microbiol. 2013 May 3;163(3-4):368-72
pubmed: 23395291
Virus Res. 1994 Mar;31(3):305-15
pubmed: 8191785
Berl Munch Tierarztl Wochenschr. 2015 Jul-Aug;128(7-8):297-303
pubmed: 26281442
Dtsch Tierarztl Wochenschr. 2006 Apr;113(4):147-51
pubmed: 16716050
Vaccine. 2003 Apr 1;21 Suppl 1:S36-40
pubmed: 12628812
Ticks Tick Borne Dis. 2015 Jul;6(5):592-600
pubmed: 26005107
Infect Dis Clin North Am. 2008 Sep;22(3):561-75, x
pubmed: 18755391
J Gen Virol. 2001 Jun;82(Pt 6):1319-1328
pubmed: 11369875
Schweiz Arch Tierheilkd. 1981 May;123(5):227-33
pubmed: 7256233
Microorganisms. 2020 Nov 18;8(11):
pubmed: 33218052
Vector Borne Zoonotic Dis. 2014 Feb;14(2):149-59
pubmed: 24359414
Ticks Tick Borne Dis. 2016 Jul;7(5):979-982
pubmed: 27189583
Rev Sci Tech. 2015 Aug;34(2):453-66
pubmed: 26601448
BMC Vet Res. 2017 Jul 11;13(1):217
pubmed: 28693561
Vector Borne Zoonotic Dis. 2011 Oct;11(10):1371-6
pubmed: 21919722
BMC Vet Res. 2017 Aug 22;13(1):267
pubmed: 28830430
J Virol Methods. 2021 Mar 8;:114122
pubmed: 33705832
Acta Vet Scand. 2009 Dec 29;51:56
pubmed: 20040077
Med Vet Entomol. 2012 Mar;26(1):18-25
pubmed: 21592155
Acta Virol. 1967 Sep;11(5):470-2
pubmed: 4383034
Acta Virol. 1972 Jul;16(4):336-40
pubmed: 4403175